Stay updated with breaking news from Single Ascending Dose Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TORONTO, Ontario and CAMBRIDGE, Massachusetts, Nov. 20, 2023 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology compan...
/PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" including its subsidiaries...
31.05.2023 - Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases, today announced the presentation of results from its Phase 1a ... Seite 1
-- Engineered IL2-Fc Cytokine is Well-tolerated and Selectively Expands Regulatory T Cells -- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies
-- Engineered IL2-Fc Cytokine is Well-tolerated and Selectively Expands Regulatory T Cells -- ... | June 7, 2023